Moderna (MRNA) Tuesday said that the U.S. Food and Drug Administration will not initiate a review of the biologics license application for its investigational influenza vaccine, mRNA-1010, and has ...
Matthew Chapman attended Rensselaer Polytechnic Institute and lives in San Marcos, Texas. Before joining Raw Story, he wrote for Shareblue and AlterNet, specializing in election and policy coverage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results